T1	Outcomes 932 958	Median time to progression
T2	Outcomes 1114 1129	median survival
T3	Outcomes 1264 1325	hematotoxicity, peripheral neuropathy, and arthralgia/myalgia
T4	Outcomes 1409 1481	ototoxicity, nausea, vomiting, and nephrotoxicity. Quality of life (QOL)